Eric Raymond

Cellular pharmacology of the combination of the DNA topoisomerase I inhibitor SN-38 and the diaminocyclohexane platinum derivative oxaliplatin.

E. Raymond, F. Goldwasser, E. Cvitkovic, 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.